• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌088AE安全性的基因与表型评估

Genetic and phenotypic assessments for the safety of probiotic 088AE.

作者信息

Saroj Dina B, Ahire Jayesh J, Shukla Rohit

机构信息

Advanced Enzyme Technologies Limited, Sun Magnetica, Louiswadi, Thane-West, Maharashtra 400 604 India.

出版信息

3 Biotech. 2023 Jul;13(7):238. doi: 10.1007/s13205-023-03662-4. Epub 2023 Jun 16.

DOI:10.1007/s13205-023-03662-4
PMID:37333714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10275836/
Abstract

In this study, we report on whole genome sequence analysis of clinically documented, commercial probiotic 088AE and genome features contributing to probiotic properties. The whole genome sequence of 088AE generated a single scaffold of 4,598,457 bp with 44.74 mol% G + C. This assembled genome sequence annotated by the RAST resulted in 4371 coding genes, 75 tRNAs, and 22 rRNAs. Gene ontology classification indicated 39.5% proteins with molecular function, 44.24% cellular component, and 16.25% proteins involved in biological processes. In taxonomic analysis, 088AE shared 99% identity with DSM 8716. The gene sequences related to safety and genome stability such as antibiotic resistance (840), virulence factors (706), biogenic amines (1), enterotoxin (0), emetic toxin (0), lanthipeptides (4), prophage (4) and clustered regularly interspaced short palindromic repeats (CRISPR) sequences (11), were identified and evaluated for safety and functions. The absence of functional prophage sequences and the presence of CRISPR indicated an advantage in genome stability. Moreover, the presence of genome features contributing to probiotic characteristics such as acid, and bile salt tolerance, adhesion to the gut mucosa, and environmental resistance ensure the strains survivability when consumed as a probiotic. In conclusion, the absence of risks associated with sequences/genes in the 088AE genome and the presence of essential probiotic traits confirm the strain to be safe for use as a probiotic.

摘要

在本研究中,我们报告了临床记录的商业益生菌088AE的全基因组序列分析以及有助于益生菌特性的基因组特征。088AE的全基因组序列产生了一个4,598,457 bp的单支架,G + C含量为44.74 mol%。通过RAST注释的该组装基因组序列产生了4371个编码基因、75个tRNA和22个rRNA。基因本体分类表明,具有分子功能的蛋白质占39.5%,细胞成分占44.24%,参与生物过程的蛋白质占16.25%。在分类分析中,088AE与DSM 8716的同一性为99%。鉴定并评估了与安全性和基因组稳定性相关的基因序列,如抗生素抗性(840个)、毒力因子(706个)、生物胺(1个)、肠毒素(0个)、呕吐毒素(0个)、羊毛硫肽(4个)、前噬菌体(4个)和规律成簇间隔短回文重复序列(CRISPR)(11个)的安全性和功能。功能性前噬菌体序列的缺失和CRISPR的存在表明在基因组稳定性方面具有优势。此外,有助于益生菌特性的基因组特征的存在,如耐酸、耐胆盐、粘附于肠粘膜和环境抗性,确保了该菌株作为益生菌食用时的生存能力。总之,088AE基因组中与序列/基因相关的风险的缺失以及必需益生菌特性的存在证实了该菌株作为益生菌使用是安全的。

相似文献

1
Genetic and phenotypic assessments for the safety of probiotic 088AE.益生菌088AE安全性的基因与表型评估
3 Biotech. 2023 Jul;13(7):238. doi: 10.1007/s13205-023-03662-4. Epub 2023 Jun 16.
2
Therapeutic efficacy of probiotic 088AE in antibiotic-associated diarrhea: A randomized controlled trial.益生菌088AE治疗抗生素相关性腹泻的疗效:一项随机对照试验。
Heliyon. 2021 Sep 15;7(9):e07993. doi: 10.1016/j.heliyon.2021.e07993. eCollection 2021 Sep.
3
Genome based safety assessment for Bacillus coagulans strain LBSC (DSM 17654) for probiotic application.基于基因组的凝结芽胞杆菌 LBSC(DSM 17654)用于益生菌应用的安全性评估。
Int J Food Microbiol. 2020 Apr 2;318:108523. doi: 10.1016/j.ijfoodmicro.2020.108523. Epub 2020 Jan 13.
4
Whole genome sequencing of KACC92338 strain with strong antioxidant activity, reveals genes and gene clusters of probiotic and antimicrobial potential.对具有强抗氧化活性的KACC92338菌株进行全基因组测序,揭示了具有益生菌和抗菌潜力的基因及基因簇。
Front Microbiol. 2024 Sep 26;15:1458221. doi: 10.3389/fmicb.2024.1458221. eCollection 2024.
5
Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina, and insights into its probiotic properties.凝结芽孢杆菌的复合基因组序列,一种以 Enterogermina 为商品名的益生菌,及其益生菌特性的研究。
BMC Microbiol. 2019 Dec 30;19(1):307. doi: 10.1186/s12866-019-1680-7.
6
Identification and characterisation of antimicrobial compound produced by probiotic Alkalihalobacillus clausii 088AE.鉴定并描述益生菌巴氏芽胞杆菌 088AE 产生的抗菌化合物。
Braz J Microbiol. 2023 Sep;54(3):1737-1743. doi: 10.1007/s42770-023-01076-1. Epub 2023 Jul 27.
7
Current Progress and Future Perspectives on the Use of Bacillus clausii.克劳氏芽孢杆菌应用的当前进展与未来展望
Microorganisms. 2022 Jun 17;10(6):1246. doi: 10.3390/microorganisms10061246.
8
Comparative accounts of probiotic properties of spore and vegetative cells of UBBC07 and in silico analysis of probiotic function.UBBC07芽孢和营养细胞益生菌特性的比较描述及益生菌功能的计算机模拟分析。
3 Biotech. 2021 Mar;11(3):116. doi: 10.1007/s13205-021-02668-0. Epub 2021 Feb 6.
9
Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores.定量和定性分析市售含有芽胞杆菌属梭菌孢子的益生菌产品的口服混悬液。
BMC Microbiol. 2022 Sep 17;22(1):217. doi: 10.1186/s12866-022-02631-w.
10
Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii.克劳氏芽孢杆菌益生菌株中存在的一种新的erm相关大环内酯抗性基因的特性分析。
Appl Environ Microbiol. 2004 Jan;70(1):280-4. doi: 10.1128/AEM.70.1.280-284.2004.

引用本文的文献

1
The Resistance Abilities of Some Species to Gastrointestinal Tract Conditions: Whole Genome Sequencing of the Novel Candidate Probiotic Strains BA8 and BA11.某些物种对胃肠道环境的抵抗能力:新型候选益生菌菌株BA8和BA11的全基因组测序
Food Sci Nutr. 2025 Feb 5;13(2):e70018. doi: 10.1002/fsn3.70018. eCollection 2025 Feb.

本文引用的文献

1
Emerging issues in probiotic safety: 2023 perspectives.益生菌安全性的新问题:2023 年的观点。
Gut Microbes. 2023 Jan-Dec;15(1):2185034. doi: 10.1080/19490976.2023.2185034.
2
Current Progress and Future Perspectives on the Use of Bacillus clausii.克劳氏芽孢杆菌应用的当前进展与未来展望
Microorganisms. 2022 Jun 17;10(6):1246. doi: 10.3390/microorganisms10061246.
3
Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition.抑菌抗生素通过促进间隔区获取来增强 CRISPR-Cas 适应性免疫。
Cell Host Microbe. 2022 Jan 12;30(1):31-40.e5. doi: 10.1016/j.chom.2021.11.014. Epub 2021 Dec 20.
4
Therapeutic efficacy of probiotic 088AE in antibiotic-associated diarrhea: A randomized controlled trial.益生菌088AE治疗抗生素相关性腹泻的疗效:一项随机对照试验。
Heliyon. 2021 Sep 15;7(9):e07993. doi: 10.1016/j.heliyon.2021.e07993. eCollection 2021 Sep.
5
Virulence Factors of Enteric Pathogenic : A Review.肠道致病菌的毒力因子:综述。
Int J Mol Sci. 2021 Sep 14;22(18):9922. doi: 10.3390/ijms22189922.
6
Comparative accounts of probiotic properties of spore and vegetative cells of UBBC07 and in silico analysis of probiotic function.UBBC07芽孢和营养细胞益生菌特性的比较描述及益生菌功能的计算机模拟分析。
3 Biotech. 2021 Mar;11(3):116. doi: 10.1007/s13205-021-02668-0. Epub 2021 Feb 6.
7
The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.CRISPR-Cas 机制用于适应性免疫和替代细菌功能,推动了多种生物技术的发展。
Front Cell Infect Microbiol. 2021 Jan 28;10:619763. doi: 10.3389/fcimb.2020.619763. eCollection 2020.
8
Survival and Germination of UBBC07 Spores in Human Gastrointestinal Tract Simulation Model and Evaluation of Clausin Production.UBBC07孢子在人体胃肠道模拟模型中的存活与萌发及Clausin产生的评估
Front Microbiol. 2020 Jun 10;11:1010. doi: 10.3389/fmicb.2020.01010. eCollection 2020.
9
Guidance on the characterisation of microorganisms used as feed additives or as production organisms.用作饲料添加剂或生产生物的微生物特性鉴定指南。
EFSA J. 2018 Mar 28;16(3):e05206. doi: 10.2903/j.efsa.2018.5206. eCollection 2018 Mar.
10
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016.2016年欧盟关于人畜共患病和指示性细菌抗微生物药物耐药性的总结报告,这些细菌来自人类、动物和食物。
EFSA J. 2018 Feb 27;16(2):e05182. doi: 10.2903/j.efsa.2018.5182. eCollection 2018 Feb.